YM90K: Pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 84-92

  Shimizu Sasamata, Masao ^a   Kawasaki Yatsugi, Sachiko ^a   Okada, Masamichi ^a   Sakamoto, Shuichi ^a   Yatsugi, Shin Ichi ^a   Togami, Junji ^a   Hatanaka, Ken Ichi ^a   Ohmori, Junya ^a   Koshiya, Kazuo ^a   Usuda, Shinji ^a   Murase, Kiyoshi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 IMIDAZOLYL) 7 NITRO 2,3 QUINOXALINEDIONE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDIOGENIC SEIZURE; BRAIN ISCHEMIA; BRAIN MEMBRANE; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GERBIL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CORPUS STRIATUM; GERBILLINAE; ISCHEMIA; MALE; MICE; MICE, INBRED DBA; QUINOXALINES; RADIOLIGAND ASSAY; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; SEIZURES;

EID: 0029927472     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. BARON, B. M., HARRISON, B. L., MCDONALD, I. A., MELDRUM, B. S., PALFREYMAN, M. G., SALITURO, F. G., SIEGEL, B. W., SLONE, A. L., TURNER, J. P. AND WHITE, H. S.: Potent indole- and qumoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site. J. Pharmacol. Exp. Ther. 262: 947-956, 1992.
2. BEAUMONT, K., CHILTON, W. S., YAMAMURA, H. I. AND ENNA, S. J.: Muscimol binding in rat brain: Association with synaptic GABA receptors. Brain Res. 148: 153-162, 1978.
3. BOAST, C. A., GERHARDT, S. C., PASTOR, G., LEHMANN, J., ETIENNE, P. E. AND LIEBMAN, J. M.: The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res. 442: 345-348, 1988.
4. BOULTER, J., HOLLMANN, M., O'SHEA-GREENFIELD, A., HARTLEY, M., DENEKIS, E., MARON, C. AND HEINEMANN, S.: Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249: 1033-1037, 1990.
5. 3H]-kainic acid receptor binding by divalent cations correlates with ion affinity for the calcium channel. Neuropharmacology 26: 1247-1251, 1987.
6. BUCHAN, A. M., XUE, D., HUANG, Z-G., SMITH, K. H. AND LESIUK, H.: Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia. Neuroreport 2: 473-476, 1991.
7. BURCHULADZE, R. AND ROSE, S. P. R.: Memory formation in day-old chicks requires NMDA but not non-NMDA glutamate receptors. Eur. J. Neurosci. 4: 533-538, 1992.
8. BUTCHER, S. P., BULLOCK, R., GRAHAM, D. I. AND MCCULLOCH, J.: Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 21: 1727-1733, 1990.
9. CHAPMAN, A. G., SMITH, S. E. AND MELDRUM, B. S.: The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res. 9: 92-96, 1991.
10. COLLINGRIDGE, G. L. AND LESTER, R. A. J.: Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40: 143-210, 1989.
11. COTMAN, C. W., MONAGHAN, D. T. AND OTTERSEN, O. P.: Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 10: 273-279, 1987.
12. DE SARRO, G. B , MELDRUM, B. S. AND NISTICO, G.: Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br. J. Pharmacol. 93: 247-256, 1988.
13. FERKANY, J. W., KYLE, D J., WILLETS, J., RZESZOTARSKI, W. J., GUZEWSKA, M. E., ELLENBERGER, S. R., JONES, S. M., SACAAN, A. I., SNELL, L. D., BOROSKY, S., JONES, B. E., JOHNSON, K. M., BALSTER, R. L., BURCHETT, K., KAWASAKI, K., HOCH, D. B. AND DINGLEDINE, R.: Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist. J. Pharmacol. Exp. Ther. 250: 100-109, 1989.
14. FINK-JENSEN, A., JUDGE, M. E., HANSEN, J. B., JACOBSEN, P., TURSKI, L., OLNEY, J. AND HONORE, T.: Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX. Neurosci. Lett. 137: 173-177, 1992.
15. FINNEY, D J.: Statistical Methods in Biological Assay, 3rd ed., Ch. 18, p. 370-403, Griffin, England, 1978.
16. GILL, R., BHAZELL, C., WOODRUFF, G. N., KEMP, J. A.: The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia. Br. J. Pharmacol. 103: 2030-2036, 1991.
17. GILL, R., NORDHOLM, L. AND LODGE, D.: The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischaemia model. Brain Res. 580: 35-43, 1992.
18. GRAHAM, S. H., SHIRAISHI, K., PANTER, S. S., SIMON, R. P. AND FADEN, A. L.: Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia. Neurosci. Lett. 110: 124-130, 1990.
19. 2+ permeability of KA-/ AMPA-gated glutamate receptor channels depends on subunit composition. Science 252: 851-853, 1991.
20. HONORE, T., DAVIES, S. N., DREJER, J., FLETCHER, E. J., JACOBSEN, P., LODGE, D. AND NIELSEN, F. E.: Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 241: 701-703, 1988.
21. 3H]-AMPA, a structural analogue of glutamic acid, to rat brain membranes. J. Neurochem. 38: 173-178, 1982.
22. 3H]-CGS-21680 a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251: 888-893, 1989.
23. KANEDA, N. AND NAGATSU, T.: Highly sensitive assay for choline acetyltransferase activity by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 341: 23-30, 1985.
24. KAWASAKI, S., YATSUGI, S., TAKAHASHI, M., KATO, M., KOSHIYA, K., SAKAMOTO, S. AND SHIMIZU-SASAMATA, M.: Postischemic administration of YM900, a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor antagonist, prevents delayed neuronal death in gerbil hippocampus. Jpn. J. Pharmacol. 60(suppl. 1): 284, 1993
25. KIRINO, T.: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239: 57-69, 1982.
26. KLOCKGETHER, T., TURSKI, L., HONORE, T., ZHANG, Z., GASH, D.M., KURLAN, R. AND GEEENMYRE, J. T.: The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys. Ann. Neurol. 30: 717-723, 1991.
27. KOEK, W., WOOD, J. H. AND WINGER, G. D.: MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol Exp. Ther. 245: 969-974, 1988.
28. KONIG, J. F. R. AND KLIPPEL, R. A.: The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Krierger, New York, 1963.
29. LEES, G. J. AND LEONG, W.: The non-NMDA glutamate antagonist NBQX blocks the local hippocampal toxicity of kainic acid, but not the diffuse extrahippocampal damage. Neurosci Lett. 143: 39-42, 1992.
30. LEESON, P. D., BAKER, R , CARLING, R. W., CURTIS, N. R., MOORE, K. W., WILLIAMS, B. J., FOSTER, A. C., DONALD, A. E., KEMP, J. A. AND MARSHALL, G. R.: Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor. J. Med. Chem. 34: 1243-1252, 1991.
31. LEESON, P. D., BAKER, R., CARLING, R. W., KULAGOWSKI, J. J., MAWER, I. M., RIDGLLL, M P., ROWLEY, M , SMITH, J. D., STANSFIELD, I., STEVENSON, G. I., FOSTER, A. C. AND KEMP, J. A.: Amino acid bioisosteres: Design of 2-quinolone derivatives as glycine-site N-methyl-D-aspartate receptor antagonists. Bioorg. Med. Chem. Lett. 3: 299-304, 1993.
32. LI, H. AND BUCHAN, A M.: Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J. Cereb. Blood Flow Metab. 13: 933-939, 1993.
33. MATSUMOTO, G., KAWATANI, M. AND TAKESHIGE, C.: Inhibitory effect of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) on the micturition reflex in rat. Neurosci. Lett. 133: 211-214, 1991.
34. MAY, P. C. AND ROBINSON, P. M.: Cyclothiazide treatment unmasks AMPA excitotoxicity in rat primary hippocampal cultures. J. Neurochem. 60: 1171-1174, 1993.
35. MELDRUM, B. S., CROUCHER, M. J., CZUCZWAR, S. J., COLLINS, J. F., CURRY, K., JOSEPH, M. AND STONE, T. W.: A comparison of the anticonvulsant potency of (±)-2-amino-5-phosphonopentanoic acid and 2-amino-7-phosphonoheptanoic acid. Neuroscience. 9: 925-930, 1983.
36. 3H]-glutamate recognition site in synaptic plasma membranes. J. Neurochem. 48: 1699-1708, 1987.
37. 3H]-glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex. J. Neurochem. 53: 370-375, 1989.
38. MONCADA, C., ARVIN, B., LE PEILLET, E. AND MELDRUM, B. S.: Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus. Neurosci. Lett 133: 287-290, 1991.
39. MORRIS, R. G. M., ANDERSON, E., LYNCH, G. S. AND BAUDRY, M.: Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319: 774-776, 1986.
40. NELLGȦRD, B. AND WIELOCH, T.: Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. 12: 2-11, 1992.
41. OHMORI, J., SAKAMOTO, S., KUBOTA, H., SHIMIZU-SASAMATA, M., OKADA, M., KAWASAKI, S., HIDAKA, K., TOGAMI, J., FURUYA, T. AND MURASE, K.: 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H, 4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: Structure-activity relationships for the AMPA-type non-NMDA receptor. J. Med. Chem. 37: 467-475, 1994
42. OKADA, M., HIDAKA, K., TOGAMI, J., OHNO, K., TADA, S., OHMORI, J., SAKAMOTO, S. AND YAMAGUCHI, T.: α-Amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) excitatory amino acid receptor antagonistic properties of YM900 (6-(1-imidazolyl)-7-nitroquinoxaline-2,3-(1H, 4H)-dione). Soc. Neurosci. Abst. 18: 87, 1992.
43. OLNEY, J. W., LABRUYERE, J. AND PRICE, M. T.: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360-1362, 1989.
44. PARADA, J., CZUCZWAR, S. J. AND TURSKI, W. A.: NBQX does not affect learning and memory tasks in mice: A comparison with D-CPPene and ifenprodil. Cognitive Brain Res. 1: 67-71, 1992.
45. PARK, C. K., MCBURNEY, R. N., HOLT, W. F., COTTER, R. E., MCCULLOCH, J., KANG, J. K. AND CHOI, C. R.: The dose-dependency of the antiischemic efficacy and of the side effects of a novel NMDA antagonist, CNS 1102 J Cereb Blood Flow Metab. 13(suppl. 1): S641, 1993.
46. PARK, C. K., NEHLS, D. G., GRAHAM, D. I., TEASDALE, G. M. AND MCCULLOCH, J.: The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24: 543-551, 1988
47. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, Sydney, 1986.
48. PULSINELLI, W. Pathophysiology of acute ischemic stroke. Lancet 339: 533-536, 1992.
49. RANDLE, J. C. R., GUET, T., BOBICHON, C., MOREAU, C., CURUTCHET, P., LAMBOLEZ, B., CARVALHO, L. P. D., CORDI, A., LEPAGNOL, J. M.: Quinoxaline derivatives: Structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-Methyl-D-aspartate receptor-mediated currents and synaptic potentials. Mol. Pharmacol. 41: 337-345, 1992.
50. REICHELT, R , HOFMANN, D., FODISH, H. J., MOHLER, H., KNAPP, M. AND HEBEBRAND, J.: Ontogeny of the benzodiazepine receptor in human brain: Fluorographic, immunochemical and reversible binding studies. J. Neurochem. 57: 1128-1135, 1991.
51. SAKAMOTO, S., OHMORI, J., SHIMIZU-SASAMATA, M., OKADA, M., KAWASAKI, S., YATSUGI, S., HIDAKA, K., TOGAMI, J., TADA, S., USUDA, S. AND MURASE, K.: Imidazolylquinoxaline-2,3-diones: Novel and potent antagonists of α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) excitatory amino acid receptor. Proceedings of the 12th International Symposium on Medicinal Chemistry, Basel, Switzerland, 1992 Abstract 28.
52. SHEARDOWN, M. J., NIELSEN, E.Ø., HANSEN, A. J., JACOBSEN, P. AND HONORE, T.: 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247: 571-574, 1990.
53. SHEARDOWN, M. J., SUZDAK, P. D. AND NORDHOLM, L.: AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur. J. Pharmacol. 236: 347-353, 1993.
54. SHIMIZU-SASAMATA, M., KAWASAKI, S., YATSUGI, S., OHMORI, J., SAKAMOTO, S., KOSHIYA, K., USUDA, S. AND MURASE, K.: The neuroprotective actions of YM900, a novel and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor antagonist, in a gerbil global ischemia model and a rat focal ischemia model. Soc. Neurosci. Abst. 18: 87, 1992.
55. SHIMIZU-SASAMATA, M., KAWASAKI, S., YATSUGI, S., OHMORI, J., SAKAMOTO, S , KOSHIYA, K., USUDA, S. AND MURASE, K.: The neuroprotective action of YM900, a novel and potent AMPA receptor antagonist, in a rat focal ischemia model. J. Cereb. Blood Flow Metab. 13 (suppl. 1): S664, 1993a.
56. SHIMIZU-SASAMATA, M., OKADA, M., SAKAMOTO, S , KAWASAKI, S., KOSHIYA, K., USUDA, S. AND MURASE, K.: The discovery of YM900 and its pharmacological characterization as a selective and potent α-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor antagonist. Jpn. J. Pharmacol. 60(suppl. 1): 164, 1993b.
57. SIESJO, B. K. AND BENGTSSON, F.: Calcium fluxes, calcium antagonists, and calcium related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis. J. Cereb. Blood Flow Metab. 9: 127-140, 1989.
58. SMITH, S. E. AND MELDRUM, B. S.: Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke 23: 861-864, 1992.
59. TAMUSA, A., GRAHAM, D. I., MCCULLOCH, J. AND TEASDALE, G. M.: Focal cerebral ischemia in the rat: Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1: 53-60, 1981.
60. TOCCO, G., SHORS, T. J., BAUDRY, M. AND THOMPSON, R. F.: Selective increase of AMPA binding to the AMPA/quisqualate receptor in the hippocampus in response to acute stress. Brain Res. 559: 168-171, 1991.
61. WEISS, J. H., KOH, J-Y., BAIMBRIDGE, K. G. AND CHOI, D. W.: Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro. Neurology 40: 1288-1292, 1990.
62. WESTERGREN, I. AND JOHANSSON, B. B.: NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema. Brain Res. 573: 324-326, 1992.
63. XUE, D., HUANG, Z-G, BARNES, K., LESIUK, H. J., SMITH, K. E. AND BUCHAN, A. M.: Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J. Cereb. Blood Flow Metab. 14: 251-261, 1994.
64. YATSUGI, S., KAWASAKI, S., KATOH, M., TAKABASHI, M., KOSHIYA, K. AND SHIMIZU-SASAMATA, M.: Effects of a novel AMPA antagonist YM900 and other excitatory amino acid antagonists on the delayed neuronal death in the gerbil hippocampus. J. Cereb. Blood Flow Metab. 13 (suppl. 1): S635, 1993.
65. ZORUMSKI, C. F., YAMADA, K. A., PRICE, M. T. AND OLNEY, J. W.: A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron 10: 61-67, 1993.